Role of β1 integrin in thrombocytopoiesis.

Faculty reviews Pub Date : 2021-09-01 eCollection Date: 2021-01-01 DOI:10.12703/r/10-68
Maria Mazzarini, Paola Verachi, Fabrizio Martelli, Anna Rita Migliaccio
{"title":"Role of β1 integrin in thrombocytopoiesis.","authors":"Maria Mazzarini,&nbsp;Paola Verachi,&nbsp;Fabrizio Martelli,&nbsp;Anna Rita Migliaccio","doi":"10.12703/r/10-68","DOIUrl":null,"url":null,"abstract":"<p><p>Thrombocytopoiesis is a complex process beginning at the level of hematopoietic stem cells, which ultimately generate megakaryocytes, large marrow cells with a distinctive morphology, and then, through a process of terminal maturation, megakaryocytes shed thousands of platelets into the circulation. This process is controlled by intrinsic and extrinsic factors. Emerging data indicate that an important intrinsic control on the late stages of thrombopoiesis is exerted by integrins, a family of transmembrane receptors composed of one α and one β subunit. One β subunit expressed by megakaryocytes is the β1 integrin, the role of which in the regulation of platelet formation is beginning to be clarified. Here, we review recent data indicating that activation of β1 integrin by outside-in and inside-out signaling regulates the interaction of megakaryocytes with the endosteal niche, which triggers their maturation, while its inactivation by galactosylation determines the migration of these cells to the perivascular niche, where they complete their terminal maturation and release platelets in the bloodstream. Furthermore, β1 integrin mediates the activation of transforming growth factor β (TGF-β), a protein produced by megakaryocytes that may act in an autocrine fashion to halt their maturation and affect the composition of their surrounding extracellular matrix. These findings suggest that β1 integrin could be a therapeutic target for inherited and acquired disorders of platelet production.</p>","PeriodicalId":73016,"journal":{"name":"Faculty reviews","volume":" ","pages":"68"},"PeriodicalIF":0.0000,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442001/pdf/","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Faculty reviews","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12703/r/10-68","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3

Abstract

Thrombocytopoiesis is a complex process beginning at the level of hematopoietic stem cells, which ultimately generate megakaryocytes, large marrow cells with a distinctive morphology, and then, through a process of terminal maturation, megakaryocytes shed thousands of platelets into the circulation. This process is controlled by intrinsic and extrinsic factors. Emerging data indicate that an important intrinsic control on the late stages of thrombopoiesis is exerted by integrins, a family of transmembrane receptors composed of one α and one β subunit. One β subunit expressed by megakaryocytes is the β1 integrin, the role of which in the regulation of platelet formation is beginning to be clarified. Here, we review recent data indicating that activation of β1 integrin by outside-in and inside-out signaling regulates the interaction of megakaryocytes with the endosteal niche, which triggers their maturation, while its inactivation by galactosylation determines the migration of these cells to the perivascular niche, where they complete their terminal maturation and release platelets in the bloodstream. Furthermore, β1 integrin mediates the activation of transforming growth factor β (TGF-β), a protein produced by megakaryocytes that may act in an autocrine fashion to halt their maturation and affect the composition of their surrounding extracellular matrix. These findings suggest that β1 integrin could be a therapeutic target for inherited and acquired disorders of platelet production.

Abstract Image

Abstract Image

Abstract Image

β1整合素在血小板生成中的作用。
血小板生成是一个复杂的过程,始于造血干细胞水平,最终产生巨核细胞,具有独特形态的大骨髓细胞,然后,通过一个终末成熟的过程,巨核细胞将数千个血小板释放到循环中。这一过程受内在和外在因素的控制。新出现的数据表明,整合素是一个跨膜受体家族,由一个α和一个β亚基组成,对血栓形成的晚期起着重要的内在控制作用。巨核细胞表达的一个β亚基是β1整合素,其在血小板形成调控中的作用开始被阐明。在这里,我们回顾了最近的数据,表明β1整合素通过由外向内和由内向外的信号激活调节巨核细胞与内皮生态位的相互作用,从而触发它们的成熟,而半乳糖基化的失活决定了这些细胞向血管周围生态位的迁移,在那里它们完成最终成熟并释放血小板到血液中。此外,β1整合素介导转化生长因子β (TGF-β)的激活,TGF-β是巨核细胞产生的一种蛋白质,可能以自分泌的方式阻止巨核细胞的成熟并影响其周围细胞外基质的组成。这些发现表明β1整合素可能是遗传性和获得性血小板生成障碍的治疗靶点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信